Private Health Insurers

MinterEllison has advised clients in the private health insurance industry for more than 30 years, giving us an in-depth understanding of the industry and regulatory regime. This includes a detailed understanding of the Private Health Insurance Act and its rules and regulations, the Health Insurance Act and the National Health Act.

We are aware of, and advise on, the key issues affecting the private health insurance sector, particularly from a legal, regulatory or procurement perspective. These issues include information technology (IT) and staffing challenges; the diversification of private health insurance products and restrictions on discounting and promotions; impediments to the take-up of preventative health initiatives; the potential impact of Commonwealth health reforms; the growing role for private health insurers in the broader health sector and a whole raft of commercial and regulatory issues (such as fund rules changes, notices to members and customer complaints, use and application of fund monies, borrowings and security).

We advise on the full spectrum of legal needs of private health insurers, including regulatory advice, mergers and acquisitions (including fund mergers and conversions to ‘for profit’), intellectual property and IT, human resources and industrial disputes, leasing, health infrastructure, competition issues, medical malpractice, and health information.

Our particular expertise is in health services procurement. We advise private health insurers, statutory authorities, government and private operators on health service purchasing contracts, ranging from complex purchaser/provider agreements for hospital treatment, to contracts for the provision of preventative health services. We have also advised on several significant technology procurement contracts in the health sector, including claims management systems and HiCaps.

Our clients include Medibank Private, Australian Unity, nib, HBF and CBHS Health Fund.

16 January 2013

On 31 December 2012, the China International Economic and Trade Arbitration Commission (CIETAC), a foreign-related arbitration commission set up by the China Council for the Promotion of International Trade (also known as the China Chamber of International Commerce) (CCPIT), released its Announcement on Issues Concerning CIETAC Shanghai Sub-Commission and CIETAC South China Sub-Commission" (the Latest Announcement). This is the latest development in a dispute, which has been on foot since April 2012, between CIETAC, the Shanghai Sub-Commission of CIETAC (CIETAC Shanghai), and the Shenzhen Court of International Arbitration (SCIA) (the CIETAC Dispute). SCIA was known as the South China Sub-Commission of CIETAC before 22 October 2012.

1 December 2011

On Tuesday, 29 November 2011, as part of its Mid-Year Economic and Fiscal Outlook 2011-12, the Federal Government announced a package of changes intended to raise A$11.5 billion in new revenue and savings.